Evans Thomas George 4
4 · Vaccitech plc · Filed May 4, 2021
Insider Transaction Report
Form 4
Vaccitech plcVACC
Evans Thomas George
Chief Scientific Officer
Transactions
- Award
Share Option (Right to Buy)
2021-04-29+364,620→ 364,620 totalExercise: $17.00Exp: 2031-04-29→ Ordinary Shares (364,620 underlying) - Award
Share Option (Right to Buy)
2021-04-29+6,942→ 6,942 totalExercise: $17.00Exp: 2031-04-29→ Ordinary Shares (6,942 underlying)
Footnotes (3)
- [F1]This option shall vest and become exercisable on April 29, 2022.
- [F2]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
- [F3]This option shall vest and become exercisable in three equal annual installments, with the first installment vesting on April 29, 2022.